To characterize autophagy-related properties in the human brain, we studied MAP1LC3A and found that its expression level in the frontal cortex of individuals with WS was lower, as compared to TD controls, although not significantly due to the high variability in the control group. Here, MAP1LC3A is linked to Werner syndrome.